The goal of the branch is to demonstrate that research findings and opportunities derived from genetic and genomic technologies may be translated into improved diagnosis, treatments and prevention of human diseases. Using the excellent resources of NHGRI intramural laboratories, the NIH Clinical Center and intramural collaborations across NIH, the branch is engaged in basic, translational and clinical research, bringing the latest genomic and genetic technologies to the study of human disease.
Our investigators develop and quickly evaluate novel translational approaches and advanced technologies. In addition, collaborations with the NIH Clinical Center, the NIH Intramural Sequencing Center and the NIH Chemical Genomics Center support projects that expand the breadth of single-investigator laboratories. The NHGRI core facilities are equally important components of all branch research efforts, giving our investigators access to state-of-the-art bioinformatic, transgenic-animal, flow-cytometry, genomic and cytogenetic technologies. These resources have allowed our investigators to develop clinical trials for gene therapy of immune deficiency and preclinical development of gene therapy for metabolic disorders. In addition, our investigators have discovered disease genes and identified small molecules to treat inherited diseases and malignancies.
Mentorship and preparation of trainees for their future careers is a priority for the branch. Branch faculty provide a broad-based learning experience for trainees that is extended and integrated with the NHGRI and NIH intramural training and seminar programs. Our investigators participate in outreach activities and learning opportunities, provide summer internships and mentor students from underrepresented groups